Dana-Farber Cancer Institute will provide production facilities for BrainStorm Cell Therapeutics' NurOwn stem cell product for use in an upcoming midstage trial. The study will begin this year at the Mayo Clinic, Massachusetts General Hospital and University of Massachusetts Hospital.
Dana-Farber, BrainStorm partner for stem cell trial
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan